Fluminense Federal University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Rio de Janeiro Brazil (1912)

Organization Overview

First Clinical Trial
2002
NCT02433912
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Denise Mafra | Federal University Fluminense | Fluminense Federal University | Otorrinolaringologia Sul-Fluminense | Otosul -Otorrinolaringologia Sul-Fluminense | Professor of Department of Anesthesiology of Federal Fluminense University | Universidade Federal Fluminense

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gingival Recession (Phase 4)

Heart Failure (Phase 2)

Inflammation (Phase 3)

Kidney Diseases (Phase 3)

Nausea (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Strabismus (Phase 3)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 30
  • # of Trial APIs: 34